Clinical Trials Directory

Trials / Completed

CompletedNCT00710515

Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies

A Phase I, Open-Label Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test if the levels of AZD6244 in blood are affected by taking food at the same time as the capsules compared to taking capsules on an empty stomach

Conditions

Interventions

TypeNameDescription
DRUGAZD624475mg

Timeline

Start date
2008-07-01
Primary completion
2009-04-01
Completion
2010-06-01
First posted
2008-07-04
Last updated
2014-08-13

Locations

6 sites across 2 countries: Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT00710515. Inclusion in this directory is not an endorsement.